# Clinical Research of Tapering UDCA in PBC Patients With a Complete Response

> **NCT04650243** · PHASE4 · RECRUITING · sponsor: **Peking Union Medical College Hospital** · enrollment: 90 (estimated)

## Conditions studied

- Primary Biliary Cholangitis

## Interventions

- **DRUG:** ursodeoxycholic acid

## Key facts

- **NCT ID:** NCT04650243
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-01-21
- **Primary completion:** 2025-05
- **Final completion:** 2025-05
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2025-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04650243

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04650243, "Clinical Research of Tapering UDCA in PBC Patients With a Complete Response". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04650243. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*